Essink, S. C. M., Zomerdijk, I. M., Straus, S. M. J. M.
, Gardarsdottir, H., & De Bruin, M. L. (2023).
Duration of Effectiveness Evaluation of Additional Risk Minimisation Measures for Centrally Authorised Medicinal Products in the EU Between 2012 and 2021.
Drug Safety,
46(10), 1007-1020.
https://doi.org/10.1007/s40264-023-01341-0https://dspace.library.uu.nl/bitstream/handle/1874/434305/s40264-023-01341-0.pdf?sequence=1